Biotech componentsEnzyme

Products 21 to 29 of 29

Luminase PB-100 by BASF
Biotech components: Enzyme
Business models: B2B
Country of production: Switzerland
Country of distribution: Germany + USA + Brazil + China
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 85,090,000 EUR
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Private Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: BASF SE (ETR)
Value chain stage: Input
Mascoma Cellulosic Ethanol (Yeast) by Lallemand + Mascoma
Biotech components: Enzyme
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 179,800,000 USD
Funding types: Venture Capital
Industry: Industrial
Market status: Under Development
Organization type(s): Private Company
Product categories: Fuel and Energy
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input
Optisochem by Bio Based Industry- Joint Undertaking (BBI-JU)
Biotech components: Enzyme + Yeast
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:10 (5 years ago)
Date last modified: 2019/09/12 15:10 (5 years ago)
Known funding amount: 16,376,817 EUR
Funding types: Government + Private Funding
Industry: Energy + Industrial
Market status: Under Development
Organization type(s): Private Company
Product categories: Chemical
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Platform
Biotech components: Enzyme
Business models: B2B + B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:35 (3 years ago)
Date last modified: 2020/12/18 14:35 (3 years ago)
Known funding amount: 5,000,000 EUR
Funding types: Venture Capital
Industry: Energy
Market status: Under Development
Organization type(s): Private Company
Product categories: Food
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Pyrolase Cellulase by BASF + Verenium
Biotech components: Enzyme
Business models: B2B
Country of production: Switzerland
Country of distribution: USA + Canada + Mexico
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2019/02/13 15:37 (5 years ago)
Known funding amount: 2,147,483,647 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Open Release
Source: SynBio Database
Trading symbol: BASF SE (XETRA)
Value chain stage: Finished Product
rHuPH20 by Halozyme
Biotech components: Enzyme
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/10/01 09:37 (5 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Health
Market status: On the market
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: Closed Production
Source: NASEM Database
Trading symbol: HALO (NASDAQ)
Value chain stage: Input
Sitagliptin by Codexis
Biotech components: Enzyme
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 37,000,000 USD
Funding types: Shareholder Investment
Industry: Health
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: CDXS (NASDAQ)
Value chain stage: Input
Stevia by Evolva
Biotech components: Enzyme
Business models: B2B
Country of production: USA
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 86,000,000 CHF
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Public Company
Product categories: Additive
Production process: Closed Production
Source: SynBio Database
Trading symbol: EVE (SWX)
Value chain stage: Finished Product
Xylathin Xylanase (#1) by BASF + Verenium
Biotech components: Enzyme
Business models: B2B
Country of production: Switzerland
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2019/05/15 15:44 (5 years ago)
Known funding amount: 2,147,483,647 EUR
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Fuel and Energy
Production process: Closed Production
Source: SynBio Database
Trading symbol: BAS (ETR)
Value chain stage: Input